Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine

Clinical trial NCT00304265 · COMPLETED

Trial details

NCT number: NCT00304265
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pertussis Diphtheria Tetanus Poliomyelitis

Start date: 2006-03-01
Primary completion: 2006-10-01
Enrollment: 215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.